Allegations of rigging in vaccine purchase: Deal for high price for Covaxin, Brazil’s Supreme Court approves investigation against President

Hindi news national Bharat Biotech Covaxin Deal News | Brazil’s Supreme Court approves Bolsonaro’s investigation into…

Assam likely to get fresh supply of vaccine on July 12 Guwahati News – Times of India

Guwahati: Assam Only after July 12 can there be some relief from ‘severe vaccine shortage’. State…

COVID-19: India delivered 43.99 lakh doses of vaccine in last 24 hours

Image Source: PTI India’s cumulative vaccination coverage rose to 34.46 crore on Saturday, according to the…

Bharat Biotech’s Covaxin found 77.8% effective in final analysis of Phase III trials

Hyderabad: Biotechnology firm Bharat Biotech on Saturday announced the efficacy and safety of indigenous vaccine Covaxin,…

Coronavirus news live updates: Covaxin 77.8% effective, says Bharat Biotech as it concludes final analysis for efficacy

Coronavirus News Live Updates: Bharat Biotech, a global leader in vaccine development and innovation, today announced…

Coronavirus News Live Updates: Drug regulatory body denied permission for Phase III trials of Sputnik Lite in India

This comes after Brazil suspended a 1.6bn reais ($321m) contract for a vaccine from India’s Bharat…

Zydus Cadila seeks emergency use authorization for its Covid-19 vaccine ZyCoV-D in India

Image Source: AP (File) Zydus Cadila seeks emergency use authorization for its Covid-19 vaccine ZyCoV-D in…

India tells EU countries: Coveshield, accept Covaxin or face mandatory quarantine

Image Source: AP Accept CovaShield, Covaxin under Green Passport Scheme, India Tells EU Countries. As the…

“Step-by-Step Approach Followed”: Bharat Biotech On Brazil Covaxin Deal Row

New Delhi: Bharat Biotech today said it has followed a step-by-step approach for contracting and regulatory…

Moderna became the fourth vaccine to be approved in India. Here’s a quick look at the other three

New Delhi: India’s immunization kit expanded with the drug regulator allowing Moderna’s COVID-19 vaccine to be…